Jeligo

Medicinal product

(Invented) name

Jeligo

Active substance (s)

Linagliptinas

Strength

5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BH05, Linagliptin

Marketing authorisation holder

Egis Pharmaceuticals PLC, Vengrija

Date of authorisation

2024-09-25

Date of renewal

Documents

5588_pakuotes lapelis_2024-09-25.docx

5588_Jeligo.docx

LT-0220_JELIGO_SD+Summ+LT_apzvalga.pdf

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

LT/H/0220/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Linagliptinas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
115172	101281	1101281	lizdinė plokštelė	N30		Receptinis	LT/1/24/5588/001	Netiekiama	-	-	No	-	-
115173	101282	1101282	dalomoji lizdinė plokštelė	N30×1		Receptinis	LT/1/24/5588/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-09-25	Registruotas